FDA Inspection 930212 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 1076406

The FDA completed an inspection of Octapharma Plasma, Inc. on May 15, 2015 in North Charleston, SC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 15, 2015
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
North Charleston, SC (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
923421 CFR 630.40(c)Notification w/in 8 weeks

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.